Show results for
Refine by
Metabolism Disease Suppliers Serving Botswana
51 companies found
based inMilpitas, CALIFORNIA (USA)
Our mission: to help accelerate the next breakthrough in drug discovery, diagnostics and basic research. We believe the scientific community goes further, faster when we go there together. We provide the research and clinical communities with expert ...
based inWuhan, CHINA
Wuhan EasyDiagnosis Biomedicine Co., Ltd was established in Wuhan Optics Valley in 2008 and went public in 2018 (Shenzhen Stock Exchange code 002932), EasyDiagnosis is a Chinese national high-tech enterprise specializing in R&D, production and sales ...
based inDublin, IRELAND
Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We offer a full range of consulting, clinical development and commercialisation services from a global network of offices in ...
based inEden Prairie, MINNESOTA (USA)
Medtimo Inc. is a newly formed subsidiary of Biorad Medisys LTD that offers an integrated portfolio of proven products and services to manage and treat obesity and metabolic disease. Their leading innovations include devices like the LAP-BAND®, ...
based inGermantown, MARYLAND (USA)
Cell and gene therapies (CGTs) use modified cells or cellular matter to treat, prevent or cure serious health issues like cancer, genetic disorders, immunodeficiencies, rare diseases, and more. CGTs have shown potential to replace damaged cells with ...
Our POCare Platform overcomes conventional processing challenges by enabling sterile, scalable onsite processing for a pipeline of advanced ...
based inSeongnam-si, SOUTH KOREA
LISCure Biosciences Provides Novel Therapeutics to Patients with Refractory Diseases Using the LMT Platform. LISCure is developing the world’s first injectable immuno-oncology program using non-pathogenic microorganisms. We focus on the development ...
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening ...
based inTokyo, JAPAN
Teijin Limited (Japan) is a global technology-driven company operating in six major fields: high-performance fibres (aramid fibres and carbon fibers), polyester fibres, films and plastics, pharmaceuticals and home health care, trading and retail, ...
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of ...
based inWokingham, UNITED KINGDOM
SGS M-Scan is a world leading group of chemical analysis laboratories specialized in chemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and ...
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to ...
based inPhiladelphia, PENNSYLVANIA (USA)
We are a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare diseases. Amicus Therapeutics (Nasdaq:FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and ...
based inNaarden, NETHERLANDS
Azafaros has leveraged on decades of discovery by professors Hans Aerts, Hermen Overkleeft, and Stan van Boeckel at Leiden University and the Academic Medical Center in the Netherlands. Expanding on their research and led by highly experienced ...
Lysosomal storage diseases (LSDs) are a group of over 70 diseases that are characterized by lysosomal dysfunction, most of which are inherited as autosomal recessive traits. These disorders are individually rare but collectively affect 1 in 5,000 ...
based inGreenfield, INDIANA (USA)
We're a leader in farm animal and pet health solutions, treating and preventing disease in more than 90 countries. A global animal health leader, we rigorously innovate to improve the health of animals, benefit our customers, support our causes and ...
based inBoston, MASSACHUSETTS (USA)
SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 790 institutions in over 70 countries. Our network advances data-driven medicine to improve health outcomes and economics worldwide. We offer a ...
Metabolic disorders are a major cause of morbidity and mortality, representing a growing health concern worldwide. Over the last decade, substantial progress has been made in the discovery of genetic variants influencing a range of ...
based inLexington, MASSACHUSETTS (USA)
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying ...
Our lead product candidate, the Revita DMR System, or Revita®, is a first-in-class procedural therapy designed to target the duodenum as a root cause of type 2 diabetes. For people with advanced type 2 diabetes, the main form of therapy to ...
based inParis, FRANCE
Metabolism is the most fundamental force driving and sustaining life At Metafora, we leverage our knowledge and understanding of cellular metabolism to develop innovative and impactful solutions that change patients’ lives. At METAFORA, we are ...
based inHuangpu District, CHINA
Moon (Guangzhou) Biotech Co., Ltd., with the title of National High-tech Enterprise, is an innovative biotechnology company focusing on the development and commercialization of microbial products and solutions. With a dedication to discover, ...
based inRensselaer, NEW YORK (USA)
Taconic Biosciences has been a leading provider of research models for over 65 years. Through all six decades, we've had a singular mission—to accelerate advancements in human health by providing our customers with the best animal model solutions. ...
One of the most used inbred mouse models, the C57BL/6 is used in nearly every research application, and it's commonly used as the genetic background for transgenic mouse models. It is also the preferred model for studying diet-induced obesity and ...
based inCambridge, UNITED KINGDOM
Owlstone Medical is developing a breathalyzer for disease. With a goal to find ways to improve non-invasive diagnostics for respiratory diseases, liver diseases, cancer, digestive health and other conditions. Our mission is to save 100,000 lives and ...
based inRoyston, UNITED KINGDOM
Volac is a fast-growing, ambitious international business and we are world leaders in dairy nutrition. We are a family-owned business and have been producing high-performance dairy nutritional products for over fifty years. We passionately believe ...
based inCambridge, MASSACHUSETTS (USA)
AOBiome has identified significant therapeutic opportunities caused by the adverse impact of the modern environment on human physiology. The human body relies on a system of multiple microorganisms, chemistries, and pathways which have shaped the ...
based inShanghai, CHINA
RareStone Group is dedicated to building the first rare disease ecosystem in China to improve the lives of patients and families impacted by rare diseases, by bringing the best-in-the-world therapeutic solutions and comprehensive and sustainable ...
Rare neurological diseases include developmental defects of the nervous system, genetic and metabolic diseases, neuroimmune diseases, neurological tumors, special types of ...